\n\n\n\n\t\t\n\t\t\tAcclarent\n\t\t\thttp://www.acclarent.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tAcclarent is a privately held medical device company. We are dedicated to the development of innovative devices providing surgeons with new technologies that better meet the needs of their ear, nose,...More»
\n\t\t\tAcclarent is a privately held medical device company. We are dedicated to the development of innovative devices providing surgeons with new technologies that better meet the needs of their ear, nose, and throat patients. Initially, we are focused on achieving the goals of sinus surgery with a novel, endoscopic, catheter-based system. Through our core technologies and commitment to innovation, Acclarent will advance novel devices in all areas of otolaryngology. Acclarent has developed the RelievaTM Balloon Sinuplasty system a novel, endoscopic, catheter-based technology for sinusitis patients. This system is a family of proprietary products cleared by the FDA and currently being used in surgical procedures throughout the U.S. and Australia.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tMenlo Park, CA, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\tacclarent,\n\t\t\t\tsurgeons,\n\t\t\t\tmedial,\n\t\t\t\tmouth,\n\t\t\t\tnose,\n\t\t\t\tsurgery,\n\t\t\t\tsinus\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series C - $35M (04/23/2007)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tMeritech Capital Partners,\n\t\t\t\t\t\n\t\tNEA,\n\t\t\t\t\t\n\t\tVersant Ventures\n\t\t\t\t
\n\t\t\tMarket
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tSinexus,\n\t\t\t\t\tAragon Surgical,\n\t\t\t\t\tEntellus Medical\n\t\t\t\t
\n\t\t\t